Published in Avian Dis on March 01, 2010
A Closer Look at the NS1 of Influenza Virus. Viruses (2009) 1.15
Influenza A(H5N2) virus antibodies in humans after contact with infected poultry, Taiwan, 2012. Emerg Infect Dis (2014) 0.84
Avian influenza virus NS1: A small protein with diverse and versatile functions. Virulence (2013) 0.78
Evaluation of sprayed hypochlorous acid solutions for their virucidal activity against avian influenza virus through in vitro experiments. J Vet Med Sci (2014) 0.78
Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol (2002) 12.70
Susceptibility of North American ducks and gulls to H5N1 highly pathogenic avian influenza viruses. Emerg Infect Dis (2006) 3.36
Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea. J Virol (2005) 2.97
Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis (2004) 2.94
Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J Virol (2004) 2.79
Development of a real-time reverse-transcription PCR for detection of newcastle disease virus RNA in clinical samples. J Clin Microbiol (2004) 2.63
The GAAS metagenomic tool and its estimations of viral and microbial average genome size in four major biomes. PLoS Comput Biol (2009) 2.61
Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol (2005) 2.51
Phylogenetic diversity among low-virulence newcastle disease viruses from waterfowl and shorebirds and comparison of genotype distributions to those of poultry-origin isolates. J Virol (2007) 2.47
Phylogenetic analyses of type A influenza genes in natural reservoir species in North America reveals genetic variation. Virus Res (2005) 2.06
Molecular analysis of highly pathogenic avian influenza virus of subtype H5N1 isolated from wild birds and mammals in northern Germany. J Gen Virol (2007) 1.94
Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One (2008) 1.91
Application of real-time RT-PCR for the quantitation and competitive replication study of H5 and H7 subtype avian influenza virus. J Virol Methods (2004) 1.88
Characterization of a highly pathogenic H5N1 avian influenza A virus isolated from duck meat. J Virol (2002) 1.85
Movements of birds and avian influenza from Asia into Alaska. Emerg Infect Dis (2007) 1.78
The pseudorabies virus UL11 protein is a virion component involved in secondary envelopment in the cytoplasm. J Virol (2003) 1.69
Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog (2008) 1.66
Characterization of class I Newcastle disease virus isolates from Hong Kong live bird markets and detection using real-time reverse transcription-PCR. J Clin Microbiol (2007) 1.65
Real time reverse transcription (RRT)-polymerase chain reaction (PCR) methods for detection of pandemic (H1N1) 2009 influenza virus and European swine influenza A virus infections in pigs. Influenza Other Respir Viruses (2010) 1.61
Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A (2006) 1.58
Development of an internal positive control for rapid diagnosis of avian influenza virus infections by real-time reverse transcription-PCR with lyophilized reagents. J Clin Microbiol (2006) 1.55
Sequence analysis of recent H7 avian influenza viruses associated with three different outbreaks in commercial poultry in the United States. J Virol (2003) 1.53
Interspecies and intraspecies transmission of triple reassortant H3N2 influenza A viruses. Virol J (2007) 1.38
Role of poultry in the spread of novel H7N9 influenza virus in China. J Virol (2014) 1.36
Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine (2007) 1.36
Removal of real-time reverse transcription polymerase chain reaction (RT-PCR) inhibitors associated with cloacal swab samples and tissues for improved diagnosis of Avian influenza virus by RT-PCR. J Vet Diagn Invest (2009) 1.35
Effect of probe-site mismatches on detection of virulent Newcastle disease viruses using a fusion-gene real-time reverse transcription polymerase chain reaction test. J Vet Diagn Invest (2006) 1.34
NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens. J Virol (2008) 1.34
Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer. Int J Cancer (2007) 1.29
Interdimensional universality of dynamic interfaces. Nature (2009) 1.27
H5N2 avian influenza outbreak in Texas in 2004: the first highly pathogenic strain in the United States in 20 years? J Virol (2005) 1.26
Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. J Virol (2006) 1.24
Real-time reverse transcription-polymerase chain reaction assays for the detection and differentiation of North American swine influenza viruses. J Vet Diagn Invest (2004) 1.18
VP1 of infectious bursal disease virus is an RNA-dependent RNA polymerase. J Gen Virol (2004) 1.18
Current status of vaccines against infectious bursal disease. Avian Pathol (2012) 1.17
Type A influenza virus detection and quantitation by real-time RT-PCR. Methods Mol Biol (2008) 1.17
Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus. J Virol (2010) 1.13
Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine (2006) 1.12
Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathol (2006) 1.11
Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens. Clin Vaccine Immunol (2006) 1.10
Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses. Avian Dis (2009) 1.10
Susceptibility of poultry to pandemic (H1N1) 2009 Virus. Emerg Infect Dis (2009) 1.09
Characterization of low-pathogenicity H5N1 avian influenza viruses from North America. J Virol (2007) 1.08
Virulent Newcastle disease virus elicits a strong innate immune response in chickens. J Gen Virol (2010) 1.08
Characterization of recent H5 subtype avian influenza viruses from US poultry. Avian Pathol (2004) 1.07
Detection of a broad range of class I and II Newcastle disease viruses using a multiplex real-time reverse transcription polymerase chain reaction assay. J Vet Diagn Invest (2008) 1.06
Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics. Virology (2006) 1.05
Molecular and structural bases for the antigenicity of VP2 of infectious bursal disease virus. J Virol (2007) 1.04
Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol (2009) 1.04
Proteome analysis of human stomach tissue: separation of soluble proteins by two-dimensional polyacrylamide gel electrophoresis and identification by mass spectrometry. Electrophoresis (2002) 1.03
Sequencing and mutational analysis of the non-coding regions of influenza A virus. Vet Microbiol (2008) 1.03
Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus. J Clin Microbiol (2005) 1.03
Overexpression of nicotinamide N-methyltransferase in gastric cancer tissues and its potential post-translational modification. Exp Mol Med (2006) 1.02
Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis (2002) 1.01
Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine. Vaccine (2008) 0.99
Comparative study on the pathogenicity and immunogenicity of wild bird isolates of avian paramyxovirus 2, 4, and 6 in chickens. Avian Pathol (2008) 0.98
Avian influenza virus RNA extraction from tissue and swab material. Methods Mol Biol (2008) 0.96
Use of a novel virus inactivation method for a multicenter avian influenza real-time reverse transcriptase-polymerase chain reaction proficiency study. J Vet Diagn Invest (2005) 0.96
Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine. Vaccine (2011) 0.95
Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine (2007) 0.95
Detection of H5N1 high-pathogenicity avian influenza virus in meat and tracheal samples from experimentally infected chickens. Avian Dis (2008) 0.95
Babinet-inverted optical Yagi-Uda antenna for unidirectional radiation to free space. Nano Lett (2014) 0.94
Suboptimal protection against H5N1 highly pathogenic avian influenza viruses from Vietnam in ducks vaccinated with commercial poultry vaccines. Vaccine (2013) 0.94
Analytical validation of a real-time reverse transcription polymerase chain reaction test for Pan-American lineage H7 subtype Avian influenza viruses. J Vet Diagn Invest (2008) 0.94
Avian influenza A virus subtype H5N2 in a red-lored Amazon parrot. J Am Vet Med Assoc (2006) 0.94
Isolation and characterization of a novel mycovirus, PeSV, in Pleurotus eryngii and the development of a diagnostic system for it. Biotechnol Lett (2006) 0.93
Proteomic analysis of early phase of conidia germination in Aspergillus nidulans. Fungal Genet Biol (2009) 0.93
Characterization of the 2012 highly pathogenic avian influenza H7N3 virus isolated from poultry in an outbreak in Mexico: pathobiology and vaccine protection. J Virol (2013) 0.93
Development and use of fowlpox vectored vaccines for avian influenza. Ann N Y Acad Sci (2006) 0.93
High-performance nanowire oxide photo-thin film transistor. Adv Mater (2013) 0.93
Prevalence of antibodies to different avian paramyxoviruses in commercial poultry in the United States. Avian Dis (2008) 0.91
Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam. Avian Dis (2010) 0.91
Association of Mx1 Asn631 variant alleles with reductions in morbidity, early mortality, viral shedding, and cytokine responses in chickens infected with a highly pathogenic avian influenza virus. Immunogenetics (2011) 0.90
Biologic characterization of H4, H6, and H9 type low pathogenicity avian influenza viruses from wild birds in chickens and turkeys. Avian Dis (2009) 0.89
Development and bench validation of real-time reverse transcription polymerase chain reaction protocols for rapid detection of the subtypes H6, H9, and H11 of avian influenza viruses in experimental samples. J Vet Diagn Invest (2007) 0.88
In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines. J Virol (2010) 0.88
Characterization of low pathogenicity avian influenza viruses isolated from wild birds in Mongolia 2005 through 2007. Virol J (2009) 0.88
Enhanced inhibitory effect of ultra-fine granules of red ginseng on LPS-induced cytokine expression in the monocyte-derived macrophage THP-1 cells. Int J Mol Sci (2008) 0.86
Interspecies and intraspecies transmission of influenza A viruses: viral, host and environmental factors. Anim Health Res Rev (2010) 0.86
Genetic characterization of highly pathogenic H5N1 avian influenza viruses isolated from poultry farms in Egypt. Virus Genes (2011) 0.86
A purified recombinant baculovirus expressed capsid protein of a new astrovirus provides partial protection to runting-stunting syndrome in chickens. Vaccine (2009) 0.85
An evaluation of avian influenza diagnostic methods with domestic duck specimens. Avian Dis (2009) 0.85
Nuclear factor NF45 interacts with viral proteins of infectious bursal disease virus and inhibits viral replication. J Virol (2010) 0.85
Vaccination of domestic ducks against H5N1 HPAI: a review. Virus Res (2013) 0.84
Identification of swine H1N2/pandemic H1N1 reassortant influenza virus in pigs, United States. Vet Microbiol (2012) 0.84
Coverage control of DNA crystals grown by silica assistance. Angew Chem Int Ed Engl (2011) 0.84
Characteristics of diagnostic tests used in the 2002 low-pathogenicity avian influenza H7N2 outbreak in Virginia. J Vet Diagn Invest (2007) 0.84
Investigation into the aetiology of runting and stunting syndrome in chickens. Avian Pathol (2012) 0.84
Differences in pathogenicity, response to vaccination, and innate immune responses in different types of ducks infected with a virulent H5N1 highly pathogenic avian influenza virus from Vietnam. Avian Dis (2012) 0.83
Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit. PLoS One (2012) 0.83
Pseudorabies virus UL3 gene codes for a nuclear protein which is dispensable for viral replication. J Virol (2004) 0.83
Bacterial surface display of GFP(uv) on bacillus subtilis spores. J Microbiol Biotechnol (2007) 0.83
Influenza virus interferon-inducing particle efficiency is reversed in avian and mammalian cells, and enhanced in cells co-infected with defective-interfering particles. J Interferon Cytokine Res (2012) 0.83
Major histocompatibility complex and background genes in chickens influence susceptibility to high pathogenicity avian influenza virus. Avian Dis (2010) 0.82
Passage of low-pathogenic avian influenza (LPAI) viruses mediates rapid genetic adaptation of a wild-bird isolate in poultry. Arch Virol (2011) 0.82